Modern fluorescence microscopy can generate images of living cells as stunning to look at as they are informative to study. For techniques like fluorescence lifetime imaging microscopy (FLIM), those ...

For over a century, doctors have used electrocardiograms (EKGs) to render the invisible electrical activity of the human ...

Building Equity Management doesn’t appear to be ready to tip its hand, but its latest acquisition is further proof that it has something in the works in Nolita. Michael Vinocur’s firm bought the ...

The Florida Python Challenge brings out a fascinating cast of characters, all captured by the director Xander Robin’s camera. By Alissa Wilkinson When you purchase a ticket for an independently ...

OpenAI’s latest voice AI model, GPT Realtime 2, introduces advanced capabilities for natural and context-aware interactions. Built on the GPT-5-level reasoning framework, it handles complex tasks such ...

OpenAI said Thursday that its API will now include a number of new voice intelligence features designed to help developers create apps that can talk, transcribe, and translate conversations with users ...

OpenAI explains in more detail what’s new with the GPT-5-class GPT-Realtime-2 voice model with reasoning: GPT‑Realtime‑2 is built for live voice interactions where the model keeps the conversation ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Two major insurers in California plan on raising rates by double digits for single-family homes, which could cause premiums to skyrocket. The AAA-affiliated Interinsurance Exchange of the Automobile ...

Kevin O’Leary, better known as Mr. Wonderful on the TV show “Shark Tank,” is joining America’s data-center gold rush. He is part of a group pursuing a 40,000-acre data-center-anchored project, which ...

WHITE OAK, MD – The US Food and Drug Administration (FDA) has announced plans for a future pilot program intended to facilitate the real-time review of clinical trials by regulators, as well as the ...

WASHINGTON, April 28 (Reuters) - The U.S. Food and Drug Administration launched a pilot program on Monday aimed at allowing the ‌agency to monitor clinical trial data in real time, a step the agency ...